Is Pepto Bismol Bad for You? Risks and Side Effects

Pepto-Bismol is not harmful for most people when used at recommended doses for short periods. The active ingredient, bismuth subsalicylate, has been sold in the United States for over a century, and at the maximum labeled daily dose, blood levels of its salicylate component stay well below toxic thresholds. The trouble starts when people use it too often, take too much, or have health conditions that change how their body handles the drug. The risks are real but largely avoidable once you know what to watch for.

What Happens in Your Body After You Swallow It

When bismuth subsalicylate reaches your stomach and intestines, it breaks apart into two components: salicylic acid and insoluble bismuth salts. Your body absorbs more than 90 percent of the salicylate portion, which then gets processed by the liver and excreted through urine. The bismuth portion is absorbed in much smaller quantities and is mostly passed out in stool. At the maximum recommended daily dose, peak salicylate concentrations in the blood remain considerably below the level associated with toxicity.¹

That salicylate component is worth paying attention to, because salicylate is the same family of compounds found in aspirin. This means Pepto-Bismol carries some of the same risks and interactions as aspirin, even though most people do not think of it that way. If you are already taking aspirin or another salicylate-containing medication, the doses can stack in ways you might not expect.

The Harmless Side Effects That Alarm People

The most common side effect of Pepto-Bismol is also the most startling: it turns your tongue and stool black. This happens because bismuth reacts with trace amounts of sulfur in your saliva and digestive tract, forming bismuth sulfide, a harmless black compound. The discoloration is temporary and clears up within a few days of stopping the medication. It has no medical significance, but it sends a surprising number of people to the emergency room or their doctor’s office fearing something serious.

Beyond the color change, the medication is generally well tolerated in clinical settings. In a trial comparing bismuth subsalicylate with another common antidiarrheal drug for acute diarrhea, both treatments were well tolerated, and none of the minor adverse effects reported led anyone to stop taking the medication.² Mild nausea and constipation can occur, but these are uncommon at standard doses and typically resolve on their own.

Chronic Overuse and Salicylate Toxicity

The most dangerous pattern with Pepto-Bismol is not a single large dose but daily use over weeks or months. Because each dose delivers salicylate into your bloodstream, chronic use allows salicylate to accumulate, especially in people whose kidneys cannot clear it efficiently. This creeping buildup is particularly insidious because the symptoms of chronic salicylate toxicity are easy to blame on other things.

A published case illustrates how this plays out. A 79-year-old man arrived at the emergency department with a week of worsening confusion, falls, and hearing loss. Doctors initially searched for infections, metabolic problems, and structural brain issues and found nothing. It was only after a more detailed medication history that they discovered he had been drinking one to two full bottles of Pepto-Bismol daily for reflux symptoms. His plasma salicylate level was elevated, and once the medication was stopped, his symptoms improved.³ The investigators noted that chronic salicylate toxicity is particularly challenging to diagnose in older adults, because confusion, unsteadiness, and hearing changes are easily attributed to aging or other medical conditions.

The key difference between this scenario and normal use is dose and duration. The labeled maximum dose is designed to keep salicylate levels safely below toxic concentrations. But people who self-medicate with Pepto-Bismol for ongoing digestive problems can easily exceed that dose, sometimes by a wide margin, without realizing they are taking what amounts to a large daily aspirin load in liquid form.

Bismuth Neurotoxicity

Separate from the salicylate issue, the bismuth portion of the drug carries its own risk when used heavily over long periods. Bismuth can accumulate in the brain and nervous system, causing a distinctive and frightening set of neurological symptoms: delirium, psychosis, poor coordination, involuntary jerking movements, and in severe cases, seizures. A case report described a patient who developed prolonged encephalopathy after using bismuth subsalicylate daily at roughly eight ounces per day. The good news is that the condition reversed over weeks to months after the bismuth intake stopped.⁴

Bismuth neurotoxicity was actually a well-recognized problem in France and Australia in the 1970s, when bismuth-containing medications were used at higher doses and for longer durations than they are today. Modern labeling limits are partly a result of that history. Still, cases continue to appear in people who exceed recommended doses on their own, and the time course of recovery can be slow enough that the experience is genuinely disabling.

Kidney Disease Changes the Math

Your kidneys are the main exit route for both salicylate and bismuth. When kidney function is impaired, both substances stick around in the body longer, reaching higher concentrations at lower doses. A systematic review of bismuth’s effects on the kidney flagged a case in which a patient with chronic kidney disease from diabetic nephropathy developed confusion, impaired hearing, and poor coordination. The patient was diagnosed with acute kidney injury on top of existing kidney disease, and the culprit was Pepto-Bismol. Intravenous fluids were given to help flush salicylate through the kidneys, and the patient’s mental status, hearing, and gait all improved after the drug was stopped.⁵

If you have any degree of kidney impairment, Pepto-Bismol deserves extra caution. The standard dose may be tolerable for a day or two, but even short courses can push salicylate levels higher than they would in someone with normal kidneys. For people on dialysis or with advanced kidney disease, the drug is generally best avoided altogether.

Interactions with Other Medications

Because Pepto-Bismol delivers salicylate into the bloodstream, it can interfere with drugs that are sensitive to salicylate levels. The most clinically serious interaction involves blood thinners. Salicylate displaces warfarin from the proteins that carry it in the blood, which pushes more warfarin into its active, free-floating form. In a documented case, a patient on warfarin therapy started taking bismuth subsalicylate for diarrhea. Within three days, the patient’s blood-clotting measurement jumped from a stable, therapeutic value to a dangerously elevated one, and minor bleeding was observed. The investigators concluded that bismuth subsalicylate should be avoided entirely during warfarin therapy.⁶

The bismuth portion creates its own drug interaction. It can bind to certain antibiotics in the gut, preventing them from being absorbed properly. When bismuth subsalicylate was given alongside a single dose of tetracycline, absorption of the antibiotic dropped by about a third, with considerable variation between individuals.⁷ This type of binding interaction extends to other tetracycline-class antibiotics and potentially to quinolone antibiotics as well. If you are taking an antibiotic and reach for Pepto-Bismol to calm your stomach, you could be undermining the antibiotic without realizing it. Spacing the doses apart by at least two hours can help, but checking with a pharmacist is the safer move.

Other medications that can interact include methotrexate, diabetes drugs that lower blood sugar, and other anti-inflammatory medications. The common thread is that salicylate can either amplify or compete with these drugs in ways that shift their effects unpredictably.

Children and the Reye’s Syndrome Concern

Pepto-Bismol labels in the United States carry a warning against use in children and teenagers who have or are recovering from a viral illness, particularly flu or chickenpox. The reason is the salicylate content. Salicylates, including aspirin, have been linked to Reye’s syndrome, a rare but potentially fatal condition that causes swelling in the liver and brain. The association between aspirin use during viral illness and Reye’s syndrome led to widespread warnings in the 1980s, and because bismuth subsalicylate delivers the same class of compound, those warnings extend to Pepto-Bismol.

In practice, many pediatricians recommend avoiding bismuth subsalicylate in children under 12 entirely, and some extend the caution through age 18. There are safer alternatives for childhood nausea and diarrhea, and the risk-benefit calculation simply does not favor a salicylate-containing medication in this age group.

Older Adults Face a Different Risk Profile

The cases of chronic toxicity described earlier share a common demographic: they tend to involve older adults. There are several reasons for this. Kidney function declines with age, even in people who have never been diagnosed with kidney disease, so salicylate and bismuth are cleared more slowly. Older adults are also more likely to be taking multiple medications, increasing the chance of a harmful interaction. And the symptoms of toxicity, such as confusion, unsteady walking, and hearing changes, overlap heavily with symptoms that doctors and families attribute to normal aging or dementia, making diagnosis harder.

The case of the 79-year-old man who was consuming one to two bottles daily went undiagnosed initially precisely because his symptoms looked like so many other things.³ Clinicians have flagged this as a recurring blind spot. If an older person develops new confusion, hearing problems, or trouble walking, and they have access to over-the-counter medications, it is worth asking specifically about Pepto-Bismol use. The product is so familiar and so widely perceived as gentle that many patients do not think to mention it when asked about their medications.

When Pepto-Bismol Tablets Fool an X-Ray

Here is a side effect that has nothing to do with your body’s chemistry: bismuth subsalicylate tablets are radiopaque, meaning they show up on X-rays and CT scans as bright, dense objects. Most medications are essentially invisible on imaging, but bismuth is a heavy metal, and in tablet form it is concentrated enough to be clearly visible in the digestive tract. This has led to cases in which Pepto-Bismol tablets were mistaken for ingested foreign bodies, coins, or other concerning findings on abdominal imaging.⁸ The liquid form usually does not cause this problem, because it is too diluted to produce the same effect.

This is unlikely to cause you any real harm, but if you have recently taken Pepto-Bismol tablets and need abdominal imaging for any reason, mentioning it to the radiologist or emergency physician can save everyone time and avoid unnecessary procedures. It falls into the category of side effects that are medically trivial but practically annoying.

Bismuth in Prescription Regimens

Bismuth is not just a folk remedy ingredient. It plays a legitimate role in some prescription regimens for wiping out Helicobacter pylori, the bacterium responsible for most stomach ulcers. Bismuth-based quadruple therapy, which pairs bismuth with a proton pump inhibitor and two antibiotics, is a standard treatment option. However, the side-effect burden of these regimens is higher than some alternatives. A network meta-analysis comparing different H. pylori treatment strategies found that bismuth-based quadruple therapy given for 14 days was associated with more adverse events than several competing regimens.⁹ The side effects in these protocols, including nausea, metallic taste, diarrhea, and darkened stools, are more frequent and noticeable than with casual over-the-counter use because the doses are higher and the duration is longer.

If your doctor prescribes a bismuth-containing regimen, the side effects are generally tolerable and the treatment course is finite, usually 10 to 14 days. The benefits of eradicating an ulcer-causing infection typically outweigh the temporary discomfort. But this context reinforces the broader point: bismuth-related side effects are dose-dependent and duration-dependent. The same compound that is mild at over-the-counter doses becomes more burdensome at prescription-level doses.

Who Should Skip It Entirely

Given everything above, some people should simply choose a different product. The groups with the clearest reasons to avoid bismuth subsalicylate include:

People on warfarin or other blood thinners: The salicylate component can dangerously amplify the anticoagulant effect.
Children and teenagers with viral illness: The salicylate raises the theoretical risk of Reye’s syndrome.
People with kidney disease: Impaired clearance allows both salicylate and bismuth to accumulate to harmful levels more quickly.
Anyone with a known salicylate or aspirin allergy: Bismuth subsalicylate delivers the same class of compound that triggers their reaction.
People already taking high-dose aspirin or other salicylates: Stacking salicylate sources raises the total body burden beyond safe levels.
Pregnant women, especially in the third trimester: Salicylates can affect fetal blood flow and prolong bleeding during delivery.

For everyone else, occasional use for a bout of traveler’s diarrhea, an upset stomach, or mild nausea is unlikely to cause problems. The drug has a long track record at recommended doses. The risks emerge at the edges: too much, too often, in people whose bodies handle the drug differently than the average healthy adult the dosing guidelines were designed around.

Why People Overuse It and What to Do Instead

A recurring theme in the case reports is that people turn to Pepto-Bismol as a daily solution for chronic digestive symptoms like acid reflux, persistent nausea, or recurring diarrhea. The product’s familiar pink branding and over-the-counter availability make it feel like something you can take indefinitely, the way you might take an antacid. But it is not an antacid in the traditional sense, and it was never designed for daily long-term use.

If you find yourself reaching for Pepto-Bismol more than a few times a week, that is a signal to investigate the underlying cause rather than keep treating the symptom. Chronic acid reflux, irritable bowel syndrome, food intolerances, and H. pylori infection all have specific treatments that are safer for ongoing use. Proton pump inhibitors, for instance, address acid production directly without delivering salicylate into your bloodstream. Antidiarrheal agents like loperamide work through a completely different mechanism and do not carry salicylate or bismuth risks. Even simple dietary changes can reduce the need for any medication at all in some cases.

The pattern of escalating self-medication is worth being honest with yourself about. The man consuming one to two bottles daily did not start there. Chronic overuse tends to creep upward gradually as tolerance builds and symptoms persist, and by the time someone is taking several times the recommended dose, they have often been doing it for weeks without telling anyone. Treating Pepto-Bismol like a short-term tool rather than a daily habit is the single most effective way to keep it in the “safe” column.